Jonathan Stuart Kaplan
Examiner (ID: 15168)
Most Active Art Unit | 2836 |
Art Unit(s) | 2107, 2104, 2836 |
Total Applications | 226 |
Issued Applications | 203 |
Pending Applications | 10 |
Abandoned Applications | 13 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7711868
[patent_doc_number] => 08092994
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-01-10
[patent_title] => 'Human virus causing respiratory tract infection and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/476019
[patent_app_country] => US
[patent_app_date] => 2009-06-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 119
[patent_figures_cnt] => 9
[patent_no_of_words] => 19462
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/092/08092994.pdf
[firstpage_image] =>[orig_patent_app_number] => 12476019
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/476019 | Human virus causing respiratory tract infection and uses thereof | May 31, 2009 | Issued |
Array
(
[id] => 5485373
[patent_doc_number] => 20090275138
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'PRODUCTION OF rAAV IN VERO CELLS USING PARTICULAR ADENOVIRUS HELPERS'
[patent_app_type] => utility
[patent_app_number] => 12/433876
[patent_app_country] => US
[patent_app_date] => 2009-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7541
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20090275138.pdf
[firstpage_image] =>[orig_patent_app_number] => 12433876
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/433876 | Production of rAAV in vero cells using particular adenovirus helpers | Apr 29, 2009 | Issued |
Array
(
[id] => 5379791
[patent_doc_number] => 20090191630
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-30
[patent_title] => 'Dual Inhibitors of HIV-1 GP-120 Interactions'
[patent_app_type] => utility
[patent_app_number] => 12/409285
[patent_app_country] => US
[patent_app_date] => 2009-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 1704
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0191/20090191630.pdf
[firstpage_image] =>[orig_patent_app_number] => 12409285
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/409285 | Dual inhibitors of HIV-1 GP-120 interactions | Mar 22, 2009 | Issued |
Array
(
[id] => 5342339
[patent_doc_number] => 20090180989
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-16
[patent_title] => 'Compositions and methods for delivering nucleotide sequences to vertebrates'
[patent_app_type] => utility
[patent_app_number] => 12/380475
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 28351
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20090180989.pdf
[firstpage_image] =>[orig_patent_app_number] => 12380475
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/380475 | Compositions and methods for delivering nucleotide sequences to vertebrates | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5480927
[patent_doc_number] => 20090203884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-13
[patent_title] => 'CHIMERIC HIV FUSION PROTEINS AS VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/358659
[patent_app_country] => US
[patent_app_date] => 2009-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11238
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0203/20090203884.pdf
[firstpage_image] =>[orig_patent_app_number] => 12358659
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/358659 | CHIMERIC HIV FUSION PROTEINS AS VACCINES | Jan 22, 2009 | Abandoned |
Array
(
[id] => 6320653
[patent_doc_number] => 20100196397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-08-05
[patent_title] => 'Five-helix protein'
[patent_app_type] => utility
[patent_app_number] => 12/321300
[patent_app_country] => US
[patent_app_date] => 2009-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 9183
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0196/20100196397.pdf
[firstpage_image] =>[orig_patent_app_number] => 12321300
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/321300 | Five-helix protein | Jan 19, 2009 | Issued |
Array
(
[id] => 5435484
[patent_doc_number] => 20090170071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'SERUM BIOMARKERS OF HEPATITIS B VIRUS INFECTED LIVER AND METHODS FOR DETECTION THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/342017
[patent_app_country] => US
[patent_app_date] => 2008-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6197
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170071.pdf
[firstpage_image] =>[orig_patent_app_number] => 12342017
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/342017 | SERUM BIOMARKERS OF HEPATITIS B VIRUS INFECTED LIVER AND METHODS FOR DETECTION THEREOF | Dec 21, 2008 | Abandoned |
Array
(
[id] => 5514311
[patent_doc_number] => 20090214617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'IMMOBILISATION AND STABILISATION OF VIRUS'
[patent_app_type] => utility
[patent_app_number] => 12/336656
[patent_app_country] => US
[patent_app_date] => 2008-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5517
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214617.pdf
[firstpage_image] =>[orig_patent_app_number] => 12336656
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/336656 | IMMOBILISATION AND STABILISATION OF VIRUS | Dec 16, 2008 | Abandoned |
Array
(
[id] => 7761643
[patent_doc_number] => 08114586
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-02-14
[patent_title] => 'Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes'
[patent_app_type] => utility
[patent_app_number] => 12/332832
[patent_app_country] => US
[patent_app_date] => 2008-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 55
[patent_figures_cnt] => 61
[patent_no_of_words] => 40292
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/114/08114586.pdf
[firstpage_image] =>[orig_patent_app_number] => 12332832
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/332832 | Prevention and treatment of HCV infection employing antibodies directed against conformational and linear epitopes | Dec 10, 2008 | Issued |
Array
(
[id] => 8163977
[patent_doc_number] => 08173375
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-08
[patent_title] => 'Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same'
[patent_app_type] => utility
[patent_app_number] => 12/290096
[patent_app_country] => US
[patent_app_date] => 2008-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 17082
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/173/08173375.pdf
[firstpage_image] =>[orig_patent_app_number] => 12290096
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/290096 | Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same | Oct 26, 2008 | Issued |
Array
(
[id] => 5545894
[patent_doc_number] => 20090155771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-18
[patent_title] => 'HEPATITIS B VIRUS DNA POLYMERASE AND SURFACE ANTIGEN VARIANTS AND METHODS OF USING SAME'
[patent_app_type] => utility
[patent_app_number] => 12/245994
[patent_app_country] => US
[patent_app_date] => 2008-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 10025
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0155/20090155771.pdf
[firstpage_image] =>[orig_patent_app_number] => 12245994
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/245994 | Hepatitis B virus DNA polymerase and surface antigen variants and methods of using same | Oct 5, 2008 | Issued |
Array
(
[id] => 5290403
[patent_doc_number] => 20090023133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-01-22
[patent_title] => 'GENOMIC MARKERS OF HEPATITIS B VIRUS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 12/208256
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9333
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20090023133.pdf
[firstpage_image] =>[orig_patent_app_number] => 12208256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/208256 | Genomic markers of hepatitis B virus associated with hepatocellular carcinoma | Sep 9, 2008 | Issued |
Array
(
[id] => 5323429
[patent_doc_number] => 20090061419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'GENOMIC MARKERS OF HEPATITIS B VIRUS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 12/208263
[patent_app_country] => US
[patent_app_date] => 2008-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9335
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20090061419.pdf
[firstpage_image] =>[orig_patent_app_number] => 12208263
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/208263 | GENOMIC MARKERS OF HEPATITIS B VIRUS ASSOCIATED WITH HEPATOCELLULAR CARCINOMA | Sep 9, 2008 | Abandoned |
Array
(
[id] => 6220576
[patent_doc_number] => 20100055671
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'Method for Determining Transduction Efficiency and Virus Dosage of Baculovirus'
[patent_app_type] => utility
[patent_app_number] => 12/203436
[patent_app_country] => US
[patent_app_date] => 2008-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 2753
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055671.pdf
[firstpage_image] =>[orig_patent_app_number] => 12203436
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/203436 | Method for Determining Transduction Efficiency and Virus Dosage of Baculovirus | Sep 2, 2008 | Abandoned |
Array
(
[id] => 8188747
[patent_doc_number] => 08182985
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Anti-TSG101 antibodies and their uses for treatment of viral infections'
[patent_app_type] => utility
[patent_app_number] => 12/184330
[patent_app_country] => US
[patent_app_date] => 2008-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22531
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/182/08182985.pdf
[firstpage_image] =>[orig_patent_app_number] => 12184330
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/184330 | Anti-TSG101 antibodies and their uses for treatment of viral infections | Jul 31, 2008 | Issued |
Array
(
[id] => 4851972
[patent_doc_number] => 20080317714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-25
[patent_title] => 'Method of Treating Hepatitis B Viral Infection'
[patent_app_type] => utility
[patent_app_number] => 12/183125
[patent_app_country] => US
[patent_app_date] => 2008-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2515
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0317/20080317714.pdf
[firstpage_image] =>[orig_patent_app_number] => 12183125
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/183125 | Method of Treating Hepatitis B Viral Infection | Jul 30, 2008 | Abandoned |
Array
(
[id] => 111863
[patent_doc_number] => 07713530
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-11
[patent_title] => 'HIV-1 subtype isolate regulatory/accessory genes, and modification and derivatives thereof'
[patent_app_type] => utility
[patent_app_number] => 12/182479
[patent_app_country] => US
[patent_app_date] => 2008-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 38
[patent_no_of_words] => 9065
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/713/07713530.pdf
[firstpage_image] =>[orig_patent_app_number] => 12182479
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/182479 | HIV-1 subtype isolate regulatory/accessory genes, and modification and derivatives thereof | Jul 29, 2008 | Issued |
Array
(
[id] => 5446060
[patent_doc_number] => 20090047286
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-02-19
[patent_title] => 'H2N3 INFLUENZA A VIRUSES AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 12/171992
[patent_app_country] => US
[patent_app_date] => 2008-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 25244
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20090047286.pdf
[firstpage_image] =>[orig_patent_app_number] => 12171992
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/171992 | H2N3 influenza A viruses and methods of use | Jul 10, 2008 | Issued |
Array
(
[id] => 4779391
[patent_doc_number] => 20080287389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-20
[patent_title] => 'Nucleoside analogs in combination therapy of herpes simplex infections'
[patent_app_type] => utility
[patent_app_number] => 12/217193
[patent_app_country] => US
[patent_app_date] => 2008-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2096
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0287/20080287389.pdf
[firstpage_image] =>[orig_patent_app_number] => 12217193
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/217193 | Nucleoside analogs in combination therapy of herpes simplex infections | Jul 1, 2008 | Abandoned |
Array
(
[id] => 5457846
[patent_doc_number] => 20090257998
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'METHOD FOR TREATING HEART ATTACKS, STROKES AND DIABETIC CRISIS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT NECESSARY PROTEIN MOLECULES AND VITAL NUTRIENTS INTO TARGETED CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/101988
[patent_app_country] => US
[patent_app_date] => 2008-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8558
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0257/20090257998.pdf
[firstpage_image] =>[orig_patent_app_number] => 12101988
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/101988 | METHOD FOR TREATING HEART ATTACKS, STROKES AND DIABETIC CRISIS BY UTILIZING MODIFIED VIRUS VIRIONS TO INSERT NECESSARY PROTEIN MOLECULES AND VITAL NUTRIENTS INTO TARGETED CELLS | Apr 11, 2008 | Abandoned |